The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule III drug, a move that would be a boon to research and patient care.

The Drug Enforcement Agency received a recommendation to reclassify cannabis as a Schedule 3 drug, a move that would be a boon to research and patient care.

Comprehensive Center for Pain and Addiction Director Todd W. Vanderah, PhD, and Medical Affairs Director Mohab M. Ibrahim, MD, PhD, spoke at the Living Health with Arthritis Tucson Lecture Series.

A new study found that the combination of chronic pain and anxiety or depression affects more than 12 million adults in the U.S.

A new study found that the combination of chronic pain and anxiety or depression affects more than 12 million adults in the U.S.

Comprehensive Center for Pain & Addiction researchers surveyed teens on both sides of the U.S.-Mexico border and found that strong family support can prevent children from using alcohol or drugs.

Comprehensive Center for Pain and Addiction researchers surveyed teens on both sides of the U.S.-Mexico border and found that strong family support can prevent children from using alcohol or drugs.

Comprehensive Center for Pain and Addiction researchers are examining the link between prolactin and endometriosis, a painful condition that affects women.

Comprehensive Center for Pain and Addiction researchers are examining the link between prolactin and endometriosis, a painful condition that affects women.

University of Arizona Health Sciences researchers will continue their study of green light therapy, a promising non-opioid pain relief option.